期刊文献+

血管紧张素转换酶2及其转换产物对心血管系统的作用 被引量:1

Effects of angiotensin-converting enzyme 2 and its products on cardiovascular system
下载PDF
导出
摘要 新近发现一种血管紧张素转换酶(ACE)同类酶,命名为血管紧张素转换酶2(ACE2),此酶在结构、功能等方面与ACE有所 不同,其转换产物血管紧张素-(1-9)和血管紧张素-(1-7)在功能上与血管紧张素转换酶转换产物AngⅡ部分相拮抗。本文就此酶 及其产物的研究做一综述。 Angiotensin-converting enzyme 2(ACE2) is the first homologue of angiotensin-converting enzyme (ACE) , it has been characterized . The effects of ACE2 are partially opposite of those of ACE . Moreover ,the effects of ACE2's products are partially opposite of those of Ang Ⅱ . In this article, we will review novel aspects of the ACE2 and its products.
出处 《中国心血管杂志》 2004年第5期382-384,共3页 Chinese Journal of Cardiovascular Medicine
关键词 血管紧张素转换酶2 心血管系统 ACE2 AngⅡ 产物 拮抗 作用 发现 Angiotensin-converting enzyme 2 AngioTensin-(l-9) Angiotensin-(1-7)
  • 相关文献

参考文献21

  • 1Donoghue M, Hsieh F, Baronas E, et al. A novel angiotensin-converting enzyme-related carboxypeptid- ase(ACE2) converts angiotensin I to angiotensin 1-9 [J]. Circ Res, 2000,87:e1-e9.
  • 2Harmer D,Gilbert M,Borman R,et al . Quantitative mRNA expression profiling of ACE2, a novel homologue of angiotensin converting enzyme [J]. FEBS Lett, 2002,4: 532 :107-110.
  • 3Riordan JF. Angiotensin- I -converting enzyme and its relatives [J]. Genome Biol, 2003,4 : 225-231.
  • 4Crackower MA, Sarao R,Oudit GY,et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function [J]. Nature, 2002 , 417:822-828.
  • 5Brodnihan KB, Neves LA , Joyner T , et al. Enhanced renal immunocytoehemical expression of ANG -(1-7) and ACE2 during pregnancy [J]. Hypertension, 2003,42 : 749-753.
  • 6Komatsu T, Suzuki Y, Imai J, et al. Molecular cloning, mRNA expression and chromosomal localization of mouse angiotensin-converting enzymerelated carboxypeptidase(mACE2)[J]. DNA Seq, 2002,13:217-220.
  • 7Boehm M, Nabel EG.. Angiotensin-eonverting enzyme 2-A new cardiac regulator [J]. N Engl J Med, 2002, 347:1795-1797.
  • 8Oudit G, Crackower MA , Backx PH, et al. The role of ACE2 in cardiovascular physiology [J]. Trends Cardiovasc Med,2003,13:93-101.
  • 9Tikellis C,Johnston LI,Forbes JM,et al. Characte-rization of renal angiotensin-converting enzyme 2 in diabetic nephropathy [J]. Hypertension, 2003, 41: 392-397.
  • 10Huang L, Sexton DJ, Skogerson K, et al. Novel peptide inhibitors of angiotensin-converting enzyme 2 [J]. J Biol Chem,2003,278 : 15532-15540.

二级参考文献38

  • 1陈伟红,谭定定,潘敬运,胡本荣.血管紧张素Ⅱ诱导左心室原癌基因c-fos和c-myc的表达[J].生理学报,1995,47(1):59-64. 被引量:8
  • 2Tallant E A,Hypertension,1997年,29卷,1Pt2期,388页
  • 3Zhu Y C,Diabetes,1996年,45卷,增1期,S5965页
  • 4Hefti MA, Harder BA, Eppenberger HM, et al. Signaling pathways in cardiac myocyte hypertrophy [J]. J Mol Cell Cardiol,1997,29:2873-2892.
  • 5Yang K, Mu XS, Xue JJ, et al. Increased expression of c-los mRNA and AP-1 transcription factors after cortical impact injury in rat[J]. Brain Res, 1994,664:141-147.
  • 6Fort P, Marty L, Piechaczyk M, et al. Various rat adult tissues express only one major mRNA species from the gluceraldehyde-3-phosphate-dehydrogenase multigenic family [J]. Nucleic Acids Res, 1985,13:1431-1442.
  • 7Takahashi M, Tsutsui H, Tagawa H, et al. Microtubules are involved in early hypertrophic response of myocardium during pressure and over load [J]. Am J Physiol, 1998, 275:H341-H348.
  • 8Sadoshima J, Jahn L, Takahashi T, et al. Molecular characterization of the stretch-induced adaptation of cultured cardiac cells[J]. J Biol Chem, 1992, 267:10551-10560.
  • 9Barka T, Van der Noen H, Shaw PA. Proto-oncogene fos (c-fos) expression in the heart [J]. Oncogene, 1987,1:439-443.
  • 10Bishopric NH, Jayasena V, Webster KA. Positive regulation of the skeletal α-actin gene by Fos and Jun in cardiac myocytes [J]. J Biol Chem, 1992, 267:25535-25540.

共引文献68

同被引文献7

  • 1[1]Ferrario CM,Chappell MC,Tallant EA,et al.Counterregulatory actions of angiotensin-(1-7)[J].Hypertension,1999; 30:535-541.
  • 2[2]Hamik A,Setiaki H,Bu G,et al.Down-regulation of monocyte tissue factor mediated by tissue factor pathway inhibitor and the low density lipoprotein receptor-related protein[J].J Biol Chem,1999 ;274:4962-4969.
  • 3[4]Pawlinski R,Pedersen B,Erlich J,et al.Role of tissue factor in haemostasis,thrombosis,angiogenesis and inflammation:lessons from low tissue factor mice[J].Thromb Haemost,2004 ;92 (3):444-450.
  • 4[5]Danilczyk U,Eriksson U,Oudit GY,et al.Physiological roles of angiotensin-converting enzyme 2[J].Cell Mol Life Sci,2004;61 (21):2714 -2719.
  • 5[7]Eatman D,Wang M,Socci RR,et al.Gender differencesin the attenuation of salt-induced hypertension by angiotensin (1-7)[J].Peptides,2001;22 (6):927-933.
  • 6[8]Tallant EA,Clark MA.Molecular mechanisms of inhibition of vascular growth by angiotensin (1-7)[J].Hypertension,2003; 42(4):574 -579.
  • 7李戈,熊石龙,文志斌,贺石林.组织因子与FⅦa的研究进展[J].血栓与止血学,2002,8(4):172-175. 被引量:3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部